The activation of JUN, along with HDAC3 and CEBPB, may form resistance to the chemotherapy and radiation therapy of hypoxic GBM; and the downregulation of the genes appeared to inhibit temozolomide on hypoxic GBM cells [46]. The gene discussed is CEBPB; the disease is glioblastoma.